Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Neuro-Oncology

• Publication date

  1991-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00165528PMID 1668406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation of biologically active platelet-derived growth factor isoforms AA and AB. Preferential formation of AB heterodimers.

  1990cited by this paper
• Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium.

  1990cited by this paper
• Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells.

  1990cited by this paper
• Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro.

  1990cited by this paper
• Epidermal growth factor receptor expression and suramin cytotoxicity in vitro.

  1990cited by this paper
• Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells.

  1990cited by this paper
• Suramin inhibits binding and degradation of platelet-derived growth factor in arterial smooth muscle cells but does not interfere with autocrine stimulation of DNA synthesis

  1989cited by this paper
• Signal transduction by the platelet-derived growth factor receptor.

  1989cited by this paper
• Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-beta.

  1989cited by this paper
• Signal transduction by the platelet-derived growth factor receptor involves association of the receptor with cytoplasmic molecules.

  1989cited by this paper
• Growth Factor Biology and Oncogene Activation in Human Gliomas and Their Implications for Specific Therapeutic Concepts

  1989cited by this paper
• Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.

  1988cited by this paper
• Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.

  1988cited by this paper
• Autocrine stimulation by the v-sis gene product requires a ligand- receptor interaction at the cell surface

  1988cited by this paper
• A human glioma cell line secretes three structurally and functionally different dimeric forms of platelet-derived growth factor.

  1988cited by this paper
• Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.

  1988cited by this paper
• Growth factors in cultured human glioma cells: differential effects of FGF, EGF and PDGF.

  1988cited by this paper
• Identification of the fibroblast growth factor receptor in human vascular endothelial cells

  1988cited by this paper
• A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets.

  1988cited by this paper
• Differentiation of a bipotential glial progenitor cell: what controls the timing and the choice of developmental pathway?

  1988cited by this paper
• A role for platelet-derived growth factor in normal gliogenesis in the central nervous system.

  1988cited by this paper
• Two classes of PDGF receptor recognize different isoforms of PDGF.

  1988cited by this paper
• Polypeptide growth factors: roles in normal and abnormal cell growth.

  1987cited by this paper
• Subversion of growth regulatory pathways in malignant transformation.

  1987cited by this paper
• Initiation of primary cell cultures from human intracranial tumors on extracellular matrix from bovine corneal endothelial cells.

  1987cited by this paper
• Human brain glial cells synthesize thrombospondin.

  1986cited by this paper
• Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia.

  1981cited by this paper

• Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomas

  2025cites this paper
• Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.

  2009cites this paper
• Molecular pathogenesis of adult brain tumors and the role of stem cells.

  2007cites this paper
• Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future

  2006influential citation
• Stein Mechanisms of Action Suramin : A Novel Antineoplastic Agent with Multiple Potential Updated Version

  2006cites this paper
• Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.

  2005cites this paper
• Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.

  2000cites this paper
• Growth Factors in Gliomas Revisited

  2000cites this paper
• Multi-agent cytostatic treatment of ‘low-grade’ gliomas

  2000cites this paper
• Suramin Treatment of Human Glioma Xenografts; Effects on Tumor Vasculature and Oxygenation Status

  1999cites this paper
• Cell surface aggregation of elastin receptor molecules caused by suramin amplified signals leading to proliferation of human glioma cells

  1999cites this paper
• Platelet-derived growth factor in human brain tumors

  1997cites this paper
• Heregulins and the ErbB-2/3/4 receptors in gliomas

  1997cites this paper
• Stimulatory effect of suramin on the proliferation of human glioma cells.

  1995cites this paper
• Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells.

  1994cites this paper
• Activated platelet‐derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line

  1994cites this paper
• The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma.

  1994cites this paper
• Suramin, a protein kinase C inhibitor, impairs hepatic regeneration.

  1994cites this paper
• Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor.

  1994cites this paper
• Cell-lines derived from human gliomas activate multiple autocrine pathways.

  1993cites this paper
• Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.

  1993cites this paper